KPV peptide protocol for the gut — the house schedule in mcg and clicks

What KPV is and what it is studied for

KPV is the C-terminal tripeptide of alpha-melanocyte-stimulating hormone — lysine, proline, valine — and it carries the anti-inflammatory part of that hormone's activity without the pigmentation part. In research settings it is studied for reducing inflammatory signalling in the gut lining, for the barrier function of the intestinal wall, and for inflammatory skin conditions. The reported effect is a quieter inflammatory baseline rather than anything a researcher feels on the day.

The single pen is for the researcher whose target is specifically the gut, or who wants to test the anti-inflammatory piece on its own before committing to the four-compound KLOW pen. The house window is 200–500 mcg a day, with 500 mcg as the soft ceiling, and the protocol below runs at the lower-middle of that window because KPV is one of the few compounds in the library where the research signal does not clearly improve with a bigger dose.

Who it suits — and who should not run it

Written for the adult researcher with an assessed gut problem — a reactive, inflamed or recently unsettled lining that a physician has looked at — who already has a dietary plan running and a baseline calprotectin to compare against. It is also written for the researcher with an inflammatory skin picture who wants the systemic rather than the topical route. The house exclusions:

Not for

• An undiagnosed gut problem — blood in the stool, unexplained weight loss or persistent pain are a physician's job first, not a peptide's.
• Active cancer or a recent cancer history.
• Pregnant, breastfeeding, or planning pregnancy in the next 6 months.
• Under 18.
• Anyone on immunosuppressive medication without their physician's explicit agreement.

Start gate: a baseline faecal calprotectin and CRP are in hand, and the dietary plan has been in place for at least two weeks so the pen is the only new variable.

The house protocol

Once daily, seven days a week, subcutaneous in the abdomen a hand's width from the navel, rotating sides, in the evening. One pen = 300 clicks. The 10 mg pen delivers 33.3 mcg per click; the 5 mg pen delivers 16.7 mcg per click, so the same dose is twice the clicks.

Two phases: a two-week run-in at 200 mcg, the bottom of the house window, then a six-week working phase at 400 mcg. 500 mcg is the soft ceiling; the window allows two injections a day, but the house schedules one, and a second dose is a personalised-protocol decision rather than a self-adjustment.

Click total on the 10 mg pen: 14 days × 6 = 84, plus 42 days × 12 = 504, for 588 clicks → 2 pens (600 clicks), leaving 12 clicks at the end of the cycle. On the 5 mg pen the same cycle is 1,176 clicks → 4 pens (1,200 clicks). Keep the pen in the fridge between uses.

KPV is one of the better-tolerated compounds in the library. Mild redness at the site is the usual report and settles within a day; anything spreading or worsening is not normal and is a same-day message to your coach.

Week by week — what people typically notice and when

The dietary plan is the protocol; the pen supports it. No reintroduction of trigger foods during the cycle — the point is to measure KPV, and a reintroduction week in the middle makes the week-8 labs unreadable. Sleep 7–9 hours, keep training as it was, and keep a simple symptom log: three words a day is enough for your coach to read a trend.

Labs we ask for before and during

Calprotectin at baseline and week 8 is non-negotiable: without it there is no way to tell a KPV effect from a good month. The absorption markers are there because a lining that is inflamed often absorbs iron and B12 poorly, and correcting those changes how a researcher feels more than any peptide does. Vitamin D, magnesium and omega-3 are the only general supplements; no new probiotics or gut supplements mid-cycle.

Stacking: what it pairs with

The natural partner is BPC-157, the other gut-lining peptide in the library — the two are studied for different parts of the same problem, repair versus inflammation, and running them as separate pens lets each be dosed at its own schedule. The KLOW pen combines KPV with BPC-157, TB-500 and GHK-Cu for the researcher whose gut, skin and recovery share one thread; KPV is already in every click of KLOW, so the single pen is never added on top.

For an inflammatory picture with an immune component, thymosin alpha-1 twice a week is the other compound in the immune corner. KPV sits quietly alongside a fat-loss cycle on retatrutide or tirzepatide when gut tolerance is the thing limiting the dose — but that combination belongs in a personalised protocol, with calprotectin on the calendar.

Common mistakes

• No baseline calprotectin. Without it, week 8 is a feeling, not a result.
• Reintroducing trigger foods mid-cycle. It makes the labs unreadable and usually makes the gut worse.
• Doubling the dose in week 3 because nothing happened in week 2. The run-in is supposed to feel like nothing. 400 mcg is the working dose; 500 mcg is the ceiling.
• Mixing up the pens. The 5 mg pen needs twice the clicks of the 10 mg pen for the same dose.
• Running it on top of KLOW. KPV is already in every click.
• Starting a new probiotic, enzyme or gut supplement in the same month. One variable at a time, or the week-8 result belongs to nobody.